AIFM1 and acute lymphoblastic leukemia: In VCR-treated G1 phase ALL cells, olaparib may block AIF-mediated DNA fragmentation, but other DNA cleavage mechanisms may operate, such as that mediated by EndoG, which also undergoes nuclear translocation (Fig. 8E).